Hyperinvasive Approach May Boost Survival in OHCA

Julia Indik, MD, PhD, University of Arizona Sarver Heart Center, College of Medicine - Tucson A “hyperinvasive” approach to treating refractory out-of-hospital cardiac arrest (OHCA) is more likely to lead to survival with neurological recovery at 6 months in some patients, according to results of a clinical trial. “What's kind of unique in this randomized trial is it's really studying a package [of] resuscitation therapies rather than just a single element,” said Dr. Julia Indik, a professor at the University of Arizona Sarver Heart Center at the College of Medicine – Tucson.